Daniel Devorsetz - Profile and Investment Details

Investor Profile

Daniel Devorsetz is a Venture Capital, Investment Bank, Private Equity Firm, Venture Debt based in Brookfield, Connecticut, United States with a diverse investment portfolio that includes companies such as CSA Medical, Aerin Medical, Titan Pharmaceuticals, GenePeeks, Bridge2 Solutions, New Haven Pharmaceuticals, IntelePeer, Alula Holdings, PebblePost, OutboundEngine, SpringCM, ScoreBig, Getaround, IntegenX, SilkRoad Technology, Nomi, Intarcia Therapeutics, Conventus Orthopaedics, Mederi Therapeutics, Audacy, Copan Systems, ZetrOZ, Mustang Bio, Ambit Biosciences, Mblox, SavingStar, Citigroup - Student Loan Corporation, Ontrak, Medsphere Systems, Castle Creek Biosciences, MacuLogix, Avalanche Technology, Interleukin Genetics, NinePoint Medical, New Signature, IgnitionOne, Meditrina, Inc, Corinth MedTech, Ceribell, Digital Signal, Palatin Technologies, Canary Medical, InVisage Technologies, Grab Media, Topia, Radisphere Radiology, Social Intelligence, Valore, Overture Networks, Argos Therapeutics, Encore Dermatology, Receptiv, AccuVein, . Over time, Daniel Devorsetz has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Daniel Devorsetz is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Cybersecurity, Women Founded, Enterprise Software, HR Tech, Design, Transportation, Android, Life Science, Retail, Marketplace, Internet of Things (IoT), Email Marketing, Collaborative Consumption, Mobile, Software, Biotechnology, Clinical Trials, Employee Benefits, Capital Raising, Consulting, PeertoPeer, Ride Sharing, Marketing, Social Media, Mergers and Acquisitions, Health Diagnostics, Medical, SaaS, Big Data, B2B, Financial Advisory, Media and Entertainment, Pharmaceuticals, Acquisitions may find it worthwhile to explore potential connections with Daniel Devorsetz, as their portfolio suggests a familiarity and interest in this area.

Understanding Daniel Devorsetz’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.